With the advent of new immuno-oncology techniques, the therapy landscape for advanced squamous non-small cell lung cancer (sq-NSCLC) is changing. Regardless of PD-L1 expression, Ivonescimab in combination with chemotherapy was…
Read More
Proudly recognized by global quality standards. These certifications demonstrate our commitment to safety, excellence, and customer trust.
